Related Experiment Video
Updated: Apr 26, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
miR-21 and let-7 in the Ras and NF-κB pathways
Saibyasachi N Choudhury, Yong Li1
1Department of Biochemistry and Molecular Biology, School of Medicine, University of Louisville, 319 Abraham Flexner Way, Louisville, KY, 40202, USA.
Abstract:
miR-21 and let-7 are two of the most studied microRNAs (miRNAs), as the former is the most frequently upregulated and the latter is the most frequently down-regulated in cancer. In this short essay, we examine the convergence of miR-21 and let-7 in two major cancer pathways: Ras and NF-κB. miR-21 suppresses multiple targets to enhance the oncogenic action of Ras, while let-7 is a direct negative regulator of the Ras gene family. let-7 is proposed to repress the activation of NF-κB through down-regulation of Ras and IL-6, while miR-21 is demonstrated to enhance NF-κB activation by down-regulating Pten and thereby increasing the activity of Akt, a kinase known to promote the NF-κB pathway. Therefore, miR-21 and let-7 contravene each other in cancer and simultaneous targeting of both is an attractive therapeutic strategy against cancers exhibiting both Ras mutations and constitutive NF-κB activation.
Insights
MicroRNAs miR-21 and let-7 have opposing roles in cancer pathways. Targeting both miR-21 and let-7 may offer a novel therapeutic strategy for cancers with Ras mutations and NF-κB activation.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression.
- miR-21 is frequently upregulated, and let-7 is downregulated in various cancers.
- Ras and NF-κB pathways are critically involved in cancer development.
Purpose of the Study:
- To investigate the opposing roles of miR-21 and let-7 in Ras and NF-κB cancer pathways.
- To explore the potential of simultaneous targeting of miR-21 and let-7 as a therapeutic strategy.
Main Methods:
- Literature review and analysis of existing studies on miR-21, let-7, Ras, and NF-κB pathways.
- Examination of molecular mechanisms by which miR-21 and let-7 regulate these pathways.
Main Results:
- miR-21 promotes oncogenic Ras signaling and enhances NF-κB activation by downregulating Pten and increasing Akt activity.
- let-7 negatively regulates Ras and represses NF-κB activation by downregulating Ras and IL-6.
- miR-21 and let-7 exhibit antagonistic functions in the context of these cancer pathways.
Conclusions:
- miR-21 and let-7 have opposing effects on critical cancer pathways, highlighting their complex interplay.
- Simultaneous targeting of both miR-21 and let-7 presents a promising therapeutic avenue for specific cancer types characterized by Ras mutations and constitutive NF-κB activation.
Related Concept Videos
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
NF-kB-dependent Signaling Pathway
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

